Compare C J Gelatine with Similar Stocks
Dashboard
With HIgh Debt (Debt-Equity Ratio at 5.01 times)- the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -10.47% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) of 2.37 times
- The company has been able to generate a Return on Equity (avg) of 7.51% signifying low profitability per unit of shareholders funds
Positive results in Mar 26
With ROCE of 4.1, it has a Fair valuation with a 1.2 Enterprise value to Capital Employed
Majority shareholders : Promoters
Market Beating Performance
Stock DNA
Specialty Chemicals
INR 10 Cr (Micro Cap)
55.00
42
0.00%
5.01
4.31%
2.35
Total Returns (Price + Dividend) 
C J Gelatine for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Broad-Based Technical Strength Lifts C J Gelatine Products Ltd to 52-Week High of Rs 20.39
With a decisive break above Rs 20.39 on 2 Jun 2026, C J Gelatine Products Ltd has reached a fresh 52-week high, extending its impressive 27.44% gain over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader Sensex trades near its own lows.
Read full news article
C J Gelatine Products Ltd Valuation Shifts: From Attractive to Fair Amid Market Gains
C J Gelatine Products Ltd, a micro-cap player in the Specialty Chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid sectoral pressures and peer comparisons, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a recalibration of price attractiveness despite recent positive returns.
Read full news article Announcements 
Appointment Of Internal Auditors
30-May-2026 | Source : BSEDisclosure for appointment of internal auditors of the Company for Finanical Year 2026-2027
Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held Today I.E. On Saturday May 30 2026
30-May-2026 | Source : BSEThe Board of Directors of the Company in its Meeting held today i.e. Saturday May 30 2026 has considered and approved the Audited Financial Results / Statements of the Company for the Quarter and Financial Year ended on March 31 2026 alongwith Auditors Report with unmodified opinions. The aforesaid Board Meeting was commenced at 01:30 P.M. (IST) and concluded at 5:15 P.M. (IST)
The Quarter And Financial Year Ended On March 31 2026 Alongwith Auditor Report.
30-May-2026 | Source : BSEIntegrated Standalone Audited Financial Results of the Company for the quarter and year ended March 31 2026 along with Statement of Assets and Liabilities Cash Flow Statement and Declaration of Unmodified Opinion for the even period and Auditors Report thereon.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Jaspal Singh (57.49%)
Krishan Kumar Amla (4.01%)
35.69%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 11.37% vs -15.63% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 54.55% vs 175.00% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 8.11% vs -5.67% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs 86.11% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 2.71% vs 0.88% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 133.33% vs 98.27% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 1.96% vs 0.98% in Mar 2025
YoY Growth in year ended Mar 2026 is 162.50% vs 104.10% in Mar 2025







